Overall rank by patents
#25,970
of 50,000 tracked assignees
USPTO PatentsView assignee record - 10 granted patents across 4 technology areas, recorded in grant years 2019–2023. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: G01N (INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES).
The verdict
According to USPTO PatentsView, Cellspect ranks #25,970 of 50,000 tracked US assignees by granted-patent volume, with 10 patents across 4 technology areas.
USPTO PatentsView assignee plate
Corpus R25970 · Foreign Corporation #25,970 · 10 grants
GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-SPARSE · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL
Nearest grant-volume peer: CDF Corporation (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
Qualcomm Incorporated · highest
85 score
Cellspect · this assignee
24 score
3D Lighting Innovati… · lowest
7 score
What this shows Cellspect's Innovation Score is 23.9/100 (top 87% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Cellspect Co., Ltd. is a focused PatentsView assignee: 4 CPC subclasses with 30% of grants classified under G01N (INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES). Peak complete grant year is 2020 (4 grants) versus a trough of 1 in 2019. By volume, Cellspect sits between CDF Corporation and Chanel.
Cellspect Co., Ltd. shows 5 grants in 2022–2024 against only 5 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
CDF Corporation
10 patents
CDI PlusOne Corp.
10 patents
CELERITASWORKS, LLC
10 patents
CELLSEED INC.
10 patents
CELLWIZE WIRELESS TECHNOLOGIES LTD.
10 patents
CENTERLINE BIOMEDICAL, INC.
10 patents
CENTRE FOR DEVELOPMENT OF TELEMATICS
10 patents
CHANEL
10 patents
CELLSPECT CO., LTD.
10 patents
What this shows Cellspect holds 10 patents at rank #25,957, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #25,957 in granted patent volume.
Other assignees with the most granted patents in Cellspect's primary technology class.
Cellspect's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
24 Top 87% higher than 13% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2019–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2019 | 1 | 10.0% |
| 2020 | 4 | 40.0% |
| 2022 | 3 | 30.0% |
| 2023 | 2 | 20.0% |
Top 4 of 4 technology areas
Overall rank by patents
#25,970
of 50,000 tracked assignees
23.9 out of 100
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.